PD0332991/Paclitaxel in Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: PD0332991|DRUG: Paclitaxel
Sponsor: Abramson Cancer Center at Penn Medicine